News Daily News Experimental FAAH Inhibitors Do Not Pose Safety Risk, FDA Concludes Michael O'Riordan August 12, 2016
News Daily News FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin Michael O'Riordan June 30, 2016
News Daily News Liraglutide Leaps Over FDA Safety Hurdle, With Cardiovascular Mortality Reduction to Boot: LEADER Michael O'Riordan June 14, 2016